firming body massage oils

1. INCI & CAS

INCI: Palmitoyl Tripeptide-1 · CAS: 147732-56-7

2. Role in the formula

Palmitoyl tripeptide-1 is a cosmetic lipopeptide. The guide uses a low ppm-to-0.05% framing and does not claim a clinical lift.

3. Typical use levels (formulation guide)

• The formulation record indicates about 2–10 ppm of pure peptide, or as the supplier blend states for serums and eye creams.

Follow the supplier blend TDS. Many trade blends are already diluted.

4. Regulatory sources & global compliance

• Treat any CosIng entry for Palmitoyl Tripeptide-1 as a reference only; verify the grade and intended use under current market rules.
• EU market placement under Regulation (EC) No 1223/2009 requires the finished product's safety, including the formula in which Palmitoyl Tripeptide-1 is used, to be assessed for the specific product as it will be marketed.
• Establish grade-specific details for Palmitoyl Tripeptide-1 from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

This entry provides guidance for cosmetic use only; this reference is not approval for drug use or OTC marketing and the final formula should undergo patch and stability assessment.

6. Stability & packaging

For bulk storage, avoid warmth and direct sun and keep the container closed; for oxidation-sensitive formulas, consider an airless or pump pack; verify the chosen pack against the tested formula.

7. Claims language (Do / Don’t)

• The listed cosmetic direction for Palmitoyl Tripeptide-1 emphasizes peptide firming.

• The available ingredient details provides no basis for claims of drug action or cure, or a product certification outside the supporting records.
• The ingredient record for Palmitoyl Tripeptide-1 provides no basis for a skin-lightening result, acne treatment, antiperspirant action, sunscreen efficacy, or hair growth.

1. INCI & CAS

INCI: Bakuchiol · CAS: 10309-37-2

2. Role in the formula

Bakuchiol is a meroterpene phenol used around 0.5–1% in cosmetic leave-ons. Do not call it vitamin A or a drug retinoid.

3. Typical use levels (formulation guide)

• For serums and creams, the recorded level is 0.5–1%.

Oil-soluble. Add in cool-down and protect from light.

4. Regulatory sources & global compliance

• Use CosIng's information on Bakuchiol as a reference, then verify the specific grade and intended use under market rules.
• EU cosmetics rules under Regulation (EC) No 1223/2009 require a safety assessment of the complete cosmetic formula containing Bakuchiol as part of the finished cosmetic's safety documentation.
• Use the supplier TDS to confirm grade-specific details for Bakuchiol and review the destination market's requirements.

5. Safety & risk assessment

The percentage is shown for cosmetic development; it does not qualify a finished product as a drug or OTC product so the finished cosmetic should receive patch and stability checks.

6. Stability & packaging

For bulk storage, avoid warmth and direct sun and keep the container closed; consider an airless or pump format when oxidation sensitivity warrants it; follow with stability and packaging checks on the confirmed batch.

7. Claims language (Do / Don’t)

• This guide frames Bakuchiol's cosmetic direction around bakuchiol.

• This formulation entry provides no basis for therapeutic outcomes, clinical cures, or a certification the finished SKU does not hold.
• The documented facts for Bakuchiol does not demonstrate whitening effects, acne treatment, antiperspirant performance, sunscreen protection, or hair growth.

1. INCI & CAS

INCI: Caprylic/Capric Triglyceride · CAS: 73398-61-5

2. Role in the formula

In lotions, balms, and cleansing oils, caprylic/capric triglyceride fills the light-oil role.

3. Typical use levels (formulation guide)

• The stated reference for lotions is 3–8% for the formula.
• For cleansing oils and balms, the reference gives 20–60%.

Incorporate Caprylic/Capric Triglyceride in the oil phase.

4. Regulatory sources & global compliance

• If CosIng lists Caprylic/Capric Triglyceride, that listing remains ingredient information; check rules for the intended market and use.
• The framework in Regulation (EC) No 1223/2009 requires the final cosmetic with Caprylic/Capric Triglyceride to undergo a safety assessment for the completed formula, not simply for an ingredient in isolation.
• Use current supplier documentation for the purchased Caprylic/Capric Triglyceride grade and verify applicable destination-market filings.

5. Safety & risk assessment

The guide records a level for cosmetic formulation purposes; it is not evidence of drug approval or OTC authorization and patch and stability testing remain part of finished-product review.

6. Stability & packaging

Hold the bulk material in a sealed, cool place shielded from light; for oxidation-sensitive formulas, consider an airless or pump pack; assess the confirmed formula for stability and package compatibility.

7. Claims language (Do / Don’t)

• For cosmetic use, this entry records Caprylic/Capric Triglyceride in a direction centered on light-triglyceride.

• The formulation note cannot verify a drug effect, a clinical cure, or certification status not established for the SKU.
• The ingredient note for Caprylic/Capric Triglyceride provides no basis for skin whitening, acne treatment, antiperspirant use, sun protection, or hair growth.